Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
09/2008
09/24/2008CN101273016A Antibacterial quinoline derivatives
09/24/2008CN101272783A (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid CB1 receptor
09/24/2008CN100420686C New [1,2,3]-thiobiazole derivative and its synthesis and use
09/24/2008CN100420678C Cyclization process for substituted benzothiazole derivatives
09/23/2008US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease
09/23/2008US7427635 2-[(S)-2-((S)-2,5-dioxo-4-phenyl-imidazolidin-1-yl)-4-methyl-pentanoylamino]-thiazole-4-carboxylic acid methyl ester; mitogen activated protein/extracellular signal regulated kinase kinase inhibitor; anticarcinogenic agent, cognition activator, nervous and autoimmune system disorders
09/23/2008US7427634 Amino acid derivatives and pharmaceutical composition comprising, as active ingredients, them
09/23/2008US7427631 especially as inhibitors of MMP12
09/23/2008US7427627 N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl)-N-phenylamines as antiproliferative compounds
09/23/2008US7427621 neurodegenerative diseases: Alzheimer's disease; amyloid plague
09/23/2008US7427620 4-{4-[4-{4-[2-(2-pyridinyl)-2-(1 H-1,2,4-triazol- 1 -yl-methyl)- 1 ,3-dioxolan-4-yl-methoxy]phenyl}- 1-piperazinyl]-phenyl}-2-( 1-methyl)-propyl-2,4-dihydro-3H-1,2,4-triazol-3-one; better toxicological profile and of reduced interaction with other drugs; good solubility in water, bioavailability
09/23/2008US7427615 3-substituted-4-pyrimidone derivatives
09/23/2008US7427608 Protection against and treatment of hearing loss
09/23/2008CA2480800C Inhibitors of akt activity
09/23/2008CA2432872C Pyrazole compounds useful as protein kinase inhibitors
09/23/2008CA2337825C Disubstituted bicyclic heterocycles, the preparation thereof and their use as pharmaceutical compositions
09/18/2008WO2008112674A1 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
09/18/2008WO2008112646A1 Aminopyridines useful as inhibitors of protein kinases
09/18/2008WO2008112498A2 Synthesis and characterization of polymorph form ii of 4-(2-(4,4-dimethyl-2-oxooxazolidin-3-yl)thiazol-4-yl)benzonitrile
09/18/2008WO2008112495A1 Synthesis and characterization of polymorph form iii of 4-(2,(4,4-dimethyl-2-oxooxazolidin-3-yl)thiazol-4-yl)benzonitrile
09/18/2008WO2008112440A1 Piperazine and piperidine mglur5 potentiators
09/18/2008WO2008112022A1 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors
09/18/2008WO2008111473A1 Glucokinase activator
09/18/2008WO2008111300A1 Novel diamide derivative
09/18/2008WO2008111299A1 Novel diamide derivative
09/18/2008WO2008110611A1 Organic compounds and their uses
09/18/2008WO2008110566A1 Compounds which potentiate ampa receptor and uses thereof in medicine
09/18/2008WO2008109991A1 Inhibitors of carnitine palmitoyltransferase and treating cancer
09/18/2008WO2008109943A1 Phenyl amino pyrimidine compounds and uses thereof
09/18/2008WO2008052930A3 Preparation of 4-alk0xy-7- (tetrahydropyran-4-yl) benzothiazol-2-amine derivatives
09/18/2008WO2007104933A8 Chemical compounds
09/18/2008WO2007090068A3 Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (hif)
09/18/2008US20080227794 Metabotropic Glutamate-Receptor-Potentiating Isoindolones
09/18/2008US20080227793 2-(1-Imidazomethyl)- or 2-(1-imidazooxy)-substituted, e.g., 6-chloro-2-{[2-(2-fluorophenyl)-1H-imidazol-1-yl]methyl}-1-propyl1H-benzimidazole; GABA receptor signal transduction; anxiety, antidepressants, sleep disorders, schizophrenia, attention deficit-hyperactivity disorder, memory enhancement
09/18/2008US20080227785 BEC 1 potassium channel inhibitors, used to treat dementia and learning disorders; e.g., N-(4-fluorophenyl)-N'-isopropyl-N''-phenyl-1,3,5-triazine-2,4,6-triamine hydrochloride
09/18/2008US20080227782 Pyrimidine amide compounds as pgds inhibitors
09/18/2008US20080227781 Imidazole compounds for the treatment of neurodegenerative disorders
09/18/2008US20080227774 5,5-disubstituted-indolizinone compounds
09/18/2008US20080227770 Benzoxazepine Compound
09/18/2008US20080226557 Generating light
09/18/2008DE102007012168A1 New thiazole derivatives useful as herbicides and plant growth regulators
09/18/2008CA2702650A1 Phenyl amino pyrimidine compounds and uses thereof
09/18/2008CA2681162A1 Benzyl and pyridine derivatives as modulators of hedgehog pathway
09/18/2008CA2680366A1 Inhibitors of carnitine palmitoyltransferase and treating cancer
09/18/2008CA2680360A1 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors
09/18/2008CA2679971A1 Glucokinase activator
09/18/2008CA2679701A1 Aminopyridines useful as inhibitors of protein kinases
09/17/2008EP1970375A1 Arylmethylene urea derivative and use thereof
09/17/2008EP1968974A1 Pestcidal compositions
09/17/2008EP1968969A2 Organic compounds
09/17/2008EP1968958A1 Substituted thiazoles and their use for producing drugs
09/17/2008EP1968957A1 Substituted thiazoles and their use for producing drugs
09/17/2008EP1968956A2 Calcium channel antagonists
09/17/2008EP1968947A1 Gaba-b receptor modulators
09/17/2008EP1968597A1 Compositions and methods for inducing neuronal differentiation
09/17/2008EP1968596A2 Calcium channel antagonists
09/17/2008EP1732892B1 Tetrahydrocarbazoles and derivatives
09/17/2008EP1495003B1 Fredericamycin derivatives
09/17/2008EP1409477B1 Piperidine derivatives as nmda receptor antagonists
09/17/2008EP1325910B1 Aliphatic nitrogenous five-membered ring compounds
09/17/2008CN101268072A DNA-PK inhibitors
09/17/2008CN101268070A Novel sulphonylpyrroles as inhibitors of HDAC novel sulphonylpyrroles
09/17/2008CN101268064A Pyrazine derivatives useful as adenosine receptor antagonists
09/17/2008CN101268060A Thiazolinones and oxazolinones and their use as PTP1B inhibitors
09/17/2008CN101265258A Organic material and application thereof in organic electroluminescence device
09/17/2008CN101265257A 2,4-disubstituted thiazolines derivatives, preparing method and application thereof
09/17/2008CN101265241A Method for preventing and curing plant disease by increasing plant immunity and use thereof
09/17/2008CN101265240A Method for preventing and curing plant disease by increasing plant immunity and use thereof
09/17/2008CN100418951C Cycloamine derivative and its use as medicine
09/17/2008CN100418948C Hydroxypyridine cgrp receptor antagonists
09/16/2008US7425638 Cis-imidazolines
09/16/2008US7425637 mitogen-activated protein/extracellular signal-regulated (MAP/ERK)Kinase pathways; 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethoxy)-amide; hyperproliferative diseases; anticarcinogenic and antiinflammatory agent
09/16/2008US7425631 Compounds and methods of use
09/16/2008US7425576 3-Azabicyclo[3.1.0]hexane-amide derivatives; human T-cell leukemia/lymphoma and lymphadenopathy associated virus, AIDS, cytomegalovirus (CMV) and Epstein-Barr virus (EBV), liver disease such as alcoholism and primary biliar cirrhosis
09/16/2008US7425555 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
09/16/2008US7425552 Antiviral agent especially to treat hepatitis C virus infections; 5-Hydroxy-4-(7-methoxy-1,1-dioxo-1,2-dihydro-1 lambda 6-benzo[1,2,4]thiadiazin-3-yl)-2-(3-methyl-butyl)-6-thiophen-2-yl-2H-py-ridazin-3-one; side effects reduction
09/16/2008US7425550 Lactam glycogen phosphorylase inhibitors and method of use
09/16/2008CA2427221C Process and intermediates for preparing anti-cancer compounds
09/12/2008WO2008109737A1 Substituted phenoxy aminothiazolones as estrogen related receptor-alpha modulators
09/12/2008WO2008109702A1 Compounds and compositions as modulators of gpr119 activity
09/12/2008WO2008109314A1 Heterocyclic compounds, compositions comprising them and methods of their use
09/12/2008WO2008109179A1 Metalloprotease inhibitors containing a squaramide moiety
09/12/2008WO2008109178A1 Metalloprotease inhibitors containing a squaramide moiety
09/12/2008WO2008108445A1 Benzoxazepine derivatives and use thereof
09/12/2008WO2008108380A2 Pyrrole compounds
09/12/2008WO2008108221A1 Cyclic guanidine ionic liquid
09/12/2008WO2008107436A1 Bicyclic organic compounds suitable for the treatment of inflammatory or allergic conditions
09/12/2008WO2008106860A1 Protein tyrosine phosphatase 1b inhibitor, preparation methods and uses thereof
09/12/2008WO2008091580A3 Fungicidal amides
09/12/2008WO2008087560A3 Thiazolidine derivatives and methods for the preparation thereof
09/12/2008WO2008073461A3 Ion channel modulators
09/12/2008WO2008073451A3 Benzoimidazole derivatives as sirtuin (sir) modulating compounds
09/12/2008WO2008070507A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
09/12/2008WO2008070016A3 Inhibitors of akt activity
09/12/2008CA2696232A1 Protein tyrosine phosphatase 1b inhibitor, preparation methods and uses thereof
09/12/2008CA2680212A1 Substituted phenoxy aminothiazolones as estrogen related receptor-.alpha. modulators
09/12/2008CA2680177A1 Metalloprotease inhibitors containing a heterocyclic moiety
09/12/2008CA2679965A1 Substituted phenoxy n-alkylated thiazolidinediones as estrogen related receptor-alpha modulators
09/12/2008CA2679564A1 Aryl sulfonamides useful for modulation of the progesterone receptor
09/12/2008CA2679305A1 Pyrrole compounds